HPV16 E4 Antibody Blocking Peptide(bs-20108P)-500ug

HPV16 E4 Antibody Blocking Pep

tide(bs-20108P)-500ug
收藏
  • ¥880
  • Bioss已认证
  • bs-20108P
  • 2025年10月16日
    avatar
    品牌商
    9钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 规格

      500ug

    产品编号bs-20108P
    英文名称HPV16 E4 Antibody Blocking Peptide
    中文名称人乳头瘤病毒16型E4封闭多肽
    英文别名E4; Human Papilloma Virus; Human papillomavirus type 16 E4; Human papillomavirus type 16 E4; Protein E4; Human Papillomavirus 16 (E4); HPV16 E4; E4 protein (HPV16); VE4_HPV16; HPV16-E4; Probable protein E4.
    纯化方法HPLC
    相似性Belongs to the papillomaviridae E4 protein family.
    功能Contributes to multiple aspects of the viral life cycle including viral genome amplification, suppression of suprabasal cell differentiation and egress of newly formed virions. Induces host cell cycle arrest at the G2 phase by associating with and preventing the nuclear entry of host CDK1/cyclin B1 complexes. Inhibits cellular DNA replication by preventing loading of host replication licensing proteins MCM2 and MCM7 onto chromatin. Within the cytoplasm, associates with host kinase SRPK1, a splicing factor regulator, and inhibits its activity. Therefore, E4 favors expression of late viral transcripts by inhibiting SRPK1-mediated phosphorylation of host serine-arginine (SR) proteins that have critical roles in mRNA metabolism. Late in the infectious cycle, E4 also acts to diminish the integrity of the keratinocyte by disrupting the keratin cytoskeleton and inducing apoptosis through alteration of mitochondrial function to facilitate egress of the newly formed virions.
    保存条件Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    背景资料The two primary oncoproteins of high risk HPV types are E6 and E7. The “E” designation indicates that these two proteins are expressed early in the HPV life cycle, while the "L" designation indicates late expression. The HPV genome is composed of six early (E1, E2, E4, E5, E6, and E7) ORFs, two late (L1 and L2) ORFs, and a non-coding long control region (LCR). After the host cell is infected viral early promoter is activated and a polycistronic primary RNA containing all six early ORFs is transcribed. This polycistronic RNA then undergoes active RNA splicing to generate multiple isoforms of mRNAs. One of the spliced isoform RNAs, E6*I, serves as an E7 mRNA to translate E7 protein. However, viral early transcription subjects to viral E2 regulation and high E2 levels repress the transcription. HPV genomes integrate into host genome by disruption of E2 ORF, preventing E2 repression on E6 and E7. Thus, viral genome integration into host DNA genome increases E6 and E7 expression to promote cellular proliferation and the chance of malignancy. The degree to which E6 and E7 are expressed is correlated with the type of cervical lesion that can ultimately develop.

     

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1680
    武汉博欧特生物科技有限公司
    2025年07月11日询价
    ¥880
    北京博奥森生物技术有限公司
    2025年10月16日询价
    ¥1759.50
    深圳欣博盛生物科技有限公司
    2025年07月16日询价
    ¥3784.50
    西宝生物科技(上海)股份有限公司
    2025年07月04日询价
    ¥1
    瑞博奥(广州)生物科技股份有限公司
    2025年07月11日询价
    HPV16 E4 Antibody Blocking Peptide(bs-20108P)-500ug
    ¥880